PROLOR Biotech, Inc., announced that the company will present data today on its long-acting clotting factors for the treatment of hemophilia at the World Federation of Hemophilia (WFH) World Congress.
URL: http://www.news-medical.net/news/20120711/PROLOR-to-present-data-on-long-acting-clotting-factors-for-hemophilia-at-WFH-World-Congress.aspx
No comments:
Post a Comment